Publication | Closed Access

Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells

Cancer ImmunosurveillanceNanotherapeuticsImmune RegulationImmunologyTumor ImmunityImmune SurveillanceOral AdministrationT Cell ImmunityImmunotherapeuticsImmunomodulationGarlic-derived NanoparticlesTumor TargetingImmunotherapyMedicineRadiation Oncology